Proteomic Profile of Saliva in Parkinson’s Disease Patients: A Proof of Concept Study
Open Access
- 18 May 2021
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 11 (5) , 661
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder. It affects many organs. Lewy bodies—a histopathological “hallmark” of PD—are detected in about 75% of PD submandibular gland samples. We hypothesize that saliva can be a source of biomarkers of PD. The aim of the study was to evaluate and compare the salivary proteome of PD patients and healthy controls (HC). Salivary samples from 39 subjects (24 PD patients, mean age 61.6 ± 8.2; 15 HC, mean age 60.9 ± 6.7) were collected. Saliva was collected using RNA-Pro-Sal kits. Label-free LC-MS/MS mass spectrometry was performed to characterize the proteome of the saliva. IPA analysis of upstream inhibitors was performed. A total of 530 proteins and peptides were identified. We observed lower concentrations of S100-A16, ARP2/3, and VPS4B in PD group when compared to HC. We conclude that the salivary proteome composition of PD patients is different than that of healthy controls. We observed a lower concentration of proteins involved in inflammatory processes, exosome formation, and adipose tissue formation. The variability of expression of proteins between the two groups needs to be considered.Keywords
Funding Information
- Warszawski Uniwersytet Medyczny (NZP/PM1/17)
This publication has 69 references indexed in Scilit:
- Malnutrition in a Sample of Community-Dwelling People with Parkinson’s DiseasePLOS ONE, 2013
- Target-Decoy Search Strategy for Mass Spectrometry-Based Proteomics2009
- An integrated LC‐ESI‐MS platform for quantitation of serum peptide ladders. Application for colon carcinoma studyProteomics – Clinical Applications, 2009
- Parkinson's disease: a dual‐hit hypothesisNeuropathology and Applied Neurobiology, 2007
- Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometryNature Methods, 2007
- Quantitative study of salivary secretion in Parkinson's diseaseMovement Disorders, 2006
- The expression of PARP, NF-κB and parvalbumin is increased in Parkinson diseaseNeuroReport, 2004
- Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activationJournal of Neurochemistry, 2003
- The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's DiseaseNeuron, 2003
- Abnormal regulation of prolactin release in idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1980